Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc C Lipman

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The European Respiratory Journal|March 7, 2015
Effective anti-tuberculosis therapy correlates with plasma small RNAIsobella Honeyborne, Marc C Lipman, Clare Eckold, et al.
Annals of Internal Medicine|August 2, 2017
Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysisDominik Zenner, Netta Beer, Ross J Harris, et al.
Journal of Medical Case Reports|March 9, 2010
Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case reportRobin H Johns, Tomas Doyle, Marc C Lipman, et al.
BMJ Open|March 28, 2014
Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK fundingMichael G Head, Joseph R Fitchett, Mary K Cooke, et al.
HIV Medicine|November 20, 2022
Estimating the risk of mortality attributable to recent late HIV diagnosis following admission to the intensive care unit: A single-centre observational cohort studyNicholas Bakewell, Tanmay Kanitkar, Oshani Dissanayake, et al.
AIDS (London, England)|September 28, 2012
No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patientsRicha Singh, Neal Marshall, Colette J Smith, et al.
AIDS (London, England)|September 27, 2005
Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infectionKeertan Dheda, Jung-Su Chang, Ronan A M Breen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Blood Transcriptomic Stratification of Short-term Risk in Contacts of TuberculosisJennifer Roe, Cristina Venturini, Rishi K Gupta, et al.
The European Respiratory Journal|August 3, 2019
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidanceHelen R Stagg, Graham H Bothamley, Jennifer A Davidson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The European Respiratory Journal|March 7, 2015
Effective anti-tuberculosis therapy correlates with plasma small RNAIsobella Honeyborne, Marc C Lipman, Clare Eckold, et al.
Annals of Internal Medicine|August 2, 2017
Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysisDominik Zenner, Netta Beer, Ross J Harris, et al.
Journal of Medical Case Reports|March 9, 2010
Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case reportRobin H Johns, Tomas Doyle, Marc C Lipman, et al.
BMJ Open|March 28, 2014
Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK fundingMichael G Head, Joseph R Fitchett, Mary K Cooke, et al.
HIV Medicine|November 20, 2022
Estimating the risk of mortality attributable to recent late HIV diagnosis following admission to the intensive care unit: A single-centre observational cohort studyNicholas Bakewell, Tanmay Kanitkar, Oshani Dissanayake, et al.
AIDS (London, England)|September 28, 2012
No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patientsRicha Singh, Neal Marshall, Colette J Smith, et al.
AIDS (London, England)|September 27, 2005
Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infectionKeertan Dheda, Jung-Su Chang, Ronan A M Breen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Blood Transcriptomic Stratification of Short-term Risk in Contacts of TuberculosisJennifer Roe, Cristina Venturini, Rishi K Gupta, et al.
The European Respiratory Journal|August 3, 2019
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidanceHelen R Stagg, Graham H Bothamley, Jennifer A Davidson, et al.
Pageof 2